Franklin Resources’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41M Buy
14,714
+1,091
+8% +$112K ﹤0.01% 2134
2026
Q1
$1.49M Sell
13,623
-601
-4% -$57.3K ﹤0.01% 2021
2025
Q4
$1.15M Sell
14,224
-93
-0.6% -$8.01K ﹤0.01% 2018
2025
Q3
$1.25M Buy
14,317
+818
+6% +$73K ﹤0.01% 1989
2025
Q2
$1.12M Buy
13,499
+212
+2% +$17.7K ﹤0.01% 1945
2025
Q1
$1.11M Sell
13,287
-391
-3% -$36.4K ﹤0.01% 1919
2024
Q4
$1.26M Buy
13,678
+1,032
+8% +$99.2K ﹤0.01% 1886
2024
Q3
$1.17M Buy
12,646
+627
+5% +$54.3K ﹤0.01% 1924
2024
Q2
$989K Buy
+12,019
New +$883K ﹤0.01% 1931

Other funds holding LMAT

Franklin Resources's LMAT Position: Q2 2026 in Review

Franklin Resources increased its LeMaitre Vascular (LMAT) stake by 8% in Q2 2026, buying an estimated $112K and bringing the position to 14,714 shares worth $1.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2134.

Franklin Resources first reported a position in LMAT in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.49M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Franklin Resources held 14,714 shares of LeMaitre Vascular worth $1.41M as of Q2 2026.
  • Franklin Resources bought 1,091 LeMaitre Vascular shares in Q2 2026, an estimated $112K.
  • LeMaitre Vascular made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2134 holding.
  • Franklin Resources first reported a position in LeMaitre Vascular in Q2 2024 and has held it in 9 quarters since.
  • Franklin Resources's LeMaitre Vascular position peaked at $1.49M in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.